{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:33:55Z","timestamp":1791203635422,"version":"4.2.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R03 MH09360601"],"award-info":[{"award-number":["R03 MH09360601"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5R01EB017268-02"],"award-info":[{"award-number":["5R01EB017268-02"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 DK072506"],"award-info":[{"award-number":["P30 DK072506"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["R883-CR07"],"award-info":[{"award-number":["R883-CR07"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["FRIZZE13XXO"],"award-info":[{"award-number":["FRIZZE13XXO"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Methods"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.ymeth.2015.09.006","type":"journal-article","created":{"date-parts":[[2015,9,7]],"date-time":"2015-09-07T02:02:22Z","timestamp":1441591342000},"page":"40-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Simple image-based no-wash method for quantitative detection of surface expressed CFTR"],"prefix":"10.1016","volume":"96","author":[{"given":"Mads Breum","family":"Larsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond A.","family":"Frizzell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon C.","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymeth.2015.09.006_b0005","doi-asserted-by":"crossref","first-page":"18843","DOI":"10.1073\/pnas.1105787108","article-title":"Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809","volume":"108","author":"Van Goor","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymeth.2015.09.006_b0010","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/thoraxjnl-2011-200393","article-title":"Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation","volume":"67","author":"Clancy","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.ymeth.2015.09.006_b0015","doi-asserted-by":"crossref","first-page":"C866","DOI":"10.1152\/ajpcell.00404.2009","article-title":"Influence of cell background on pharmacological rescue of mutant CFTR","volume":"298","author":"Pedemonte","year":"2010","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ymeth.2015.09.006_b0020","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1056\/NEJMoa1409547","article-title":"Lumacaftor\u2013ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR","volume":"373","author":"Wainwright","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymeth.2015.09.006_b0025","doi-asserted-by":"crossref","first-page":"246ra97","DOI":"10.1126\/scitranslmed.3008889","article-title":"Some gating potentiators, including VX-770, diminish \u0394F508-CFTR functional expression","volume":"6","author":"Veit","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymeth.2015.09.006_b0030","doi-asserted-by":"crossref","first-page":"246ra96","DOI":"10.1126\/scitranslmed.3008680","article-title":"Potentiator ivacaftor abrogates pharmacological correction of \u0394F508 CFTR in cystic fibrosis","volume":"6","author":"Cholon","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymeth.2015.09.006_b0035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-1-61779-117-8_2","article-title":"High-throughput screening of libraries of compounds to identify CFTR modulators","volume":"741","author":"Pedemonte","year":"2011","journal-title":"Methods Mol. Biol. (Clifton, NJ)"},{"key":"10.1016\/j.ymeth.2015.09.006_b0040","doi-asserted-by":"crossref","first-page":"L1117","DOI":"10.1152\/ajplung.00169.2005","article-title":"Rescue of DeltaF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules","volume":"290","author":"Van Goor","year":"2006","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.ymeth.2015.09.006_b0045","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1042\/BJ20070478","article-title":"Additive effect of multiple pharmacological chaperones on maturation of CFTR processing mutants","volume":"406","author":"Wang","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymeth.2015.09.006_b0050","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1124\/mol.106.029926","article-title":"Modulating the folding of P-glycoprotein and cystic fibrosis transmembrane conductance regulator truncation mutants with pharmacological chaperones","volume":"71","author":"Wang","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ymeth.2015.09.006_b0055","doi-asserted-by":"crossref","first-page":"31123","DOI":"10.1074\/jbc.274.44.31123","article-title":"Correction of defective protein trafficking of a mutant HERG potassium channel in human long QT syndrome. Pharmacological and temperature effects","volume":"274","author":"Zhou","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymeth.2015.09.006_b0060","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.1074\/jbc.M107345200","article-title":"The binding site for channel blockers that rescue misprocessed human long QT syndrome type 2 ether-a-gogo-related gene (HERG) mutations","volume":"277","author":"Ficker","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymeth.2015.09.006_b0065","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1034\/j.1600-0854.2000.011104.x","article-title":"Traffic jam: a compendium of human diseases that affect intracellular transport processes","volume":"1","author":"Aridor","year":"2000","journal-title":"Traffic"},{"key":"10.1016\/j.ymeth.2015.09.006_b0070","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nbt1368","article-title":"Fluorogen-activating single-chain antibodies for imaging cell surface proteins","volume":"26","author":"Szent-Gyorgyi","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymeth.2015.09.006_b0075","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2119\/molmed.2012.00001","article-title":"Pharmacological rescue of the mutant cystic fibrosis transmembrane conductance regulator (CFTR) detected by use of a novel fluorescence platform","volume":"18","author":"Holleran","year":"2012","journal-title":"Mol. Med. (Cambridge, MA)"},{"key":"10.1016\/j.ymeth.2015.09.006_b0080","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J. Biomol. Screen."}],"container-title":["Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046202315300797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046202315300797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T01:02:57Z","timestamp":1572397377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1046202315300797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":16,"alternative-id":["S1046202315300797"],"URL":"https:\/\/doi.org\/10.1016\/j.ymeth.2015.09.006","relation":{},"ISSN":["1046-2023"],"issn-type":[{"value":"1046-2023","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simple image-based no-wash method for quantitative detection of surface expressed CFTR","name":"articletitle","label":"Article Title"},{"value":"Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymeth.2015.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}